AtonRa Partners’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $152K | Sell |
16,834
-2,136
| -11% | -$19.3K | 0.3% | 116 |
|
|
2023
Q3 | $121K | Sell |
18,970
-3,468
| -15% | -$22.1K | 0.25% | 120 |
|
|
2023
Q2 | $249K | Sell |
22,438
-2,077
| -8% | -$23K | 0.39% | 109 |
|
|
2023
Q1 | $376K | Sell |
24,515
-2,262
| -8% | -$34.7K | 0.55% | 85 |
|
|
2022
Q4 | $594K | Sell |
26,777
-7,242
| -21% | -$161K | 0.76% | 60 |
|
|
2022
Q3 | $556K | Sell |
34,019
-627
| -2% | -$10.2K | 0.55% | 84 |
|
|
2022
Q2 | $503K | Sell |
34,646
-5,473
| -14% | -$79.5K | 0.46% | 99 |
|
|
2022
Q1 | $741K | Buy |
40,119
+2,297
| +6% | +$42.4K | 0.4% | 90 |
|
|
2021
Q4 | $899K | Buy |
+37,822
| New | +$899K | 0.31% | 97 |
|